Meta-analysis of the association between a polymorphism in MicroRNA-196a2 and susceptibility to colorectal cancer

Onkologie(Czech Republic)

Volumn 36, Issue 10, 2013, Pages 560-565

  Shi, Ke Qing ^a   Lin, Zhuo ^a   Li, De Wei ^b   Fang, Yu Xiao ^c   Gao, Jian ^b   Deng, Zhu Jun ^c   Chen, Li ^c   Li, Gui Ling ^c   Wu, Jian Min ^c   Tang, Kai Fu ^c  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

^c WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer; Meta analysis; MicroRNA; Single nucleotide polymorphisms; Systematic review

Indexed keywords

MICRORNA; MICRORNA 196A2; UNCLASSIFIED DRUG;

ARTICLE; ASIAN; CANCER RISK; COLORECTAL CANCER; ETHNICITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; SYSTEMATIC REVIEW;

COLORECTAL NEOPLASMS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK FACTORS;

EID: 84885658690     PISSN: 0378584X     EISSN: 14230240     Source Type: Journal    
DOI: 10.1159/000355158     Document Type: Article

References (24)

1. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
2. Yi M, Xu J, Liu P, Chang GJ, Du XL, Hu CY, Song Y, He J, Ren Y, Wei Y, Yang J, Hunt KK, Li X: Comparative analysis of lifestyle factors, screening test use, and clinicopathologic features in association with survival among Asian Americans with colorectal cancer. Br J Cancer 2013;108:1508-1514.
3. Goel A, Boland CR: Epigenetics of colorectal cancer. Gastroenterology 2012;143:1442-1460.
4. Baer C, Claus R, Plass C: Genome-wide epigenetic regulation of miRNAs in cancer. Cancer Res 2013; 73:473-477.
5. Nana-Sinkam SP, Croce CM: Clinical applications for microRNAs in cancer. Clin Pharmacol Ther 2013;93:98-104.
6. Kasinski AL, Slack FJ: Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 2011;11:849-864.
7. Ryan BM, Robles AI, Harris CC: Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 2010;10:389-402.
8. Mishra PJ, Banerjee D, Bertino JR: MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: introducing micro- RNA pharmacogenomics. Cell Cycle 2008;7:853-858.
9. Schetter AJ, Harris CC: Alterations of microRNAs contribute to colon carcinogenesis. Semin Oncol 2011;38:734-742.
10. Zhan JF, Chen LH, Chen ZX, Yuan YW, Xie GZ, Sun AM, Liu Y: A functional variant in microRNA- 196a2 is associated with susceptibility of colorectal cancer in a Chinese population. Arch Med Res 2011;42:144-148.
11. Zhu L, Chu H, Gu D, Ma L, Shi D, Zhong D, Tong N, Zhang Z, Wang M: A functional polymorphism in miRNA-196a2 is associated with colorectal cancer risk in a Chinese population. DNA Cell Biol 2012;31:350-354.
12. Chen H, Sun LY, Chen LL, Zheng HQ, Zhang QF: A variant in microRNA-196a2 is not associated with susceptibility to and progression of colorectal cancer in Chinese. Intern Med J 2012;42:e115-e119.
13. Hezova R, Kovarikova A, Bienertova-Vasku J, Sachlova M, Redova M, Vasku A, Svoboda M, Radova L, Kiss I, Vyzula R, Slaby O: Evaluation of SNPs in miR-196-A2, miR-27a and miR-146a as risk factors of colorectal cancer. World J Gastroenterol 2012;18:2827-2831.
14. Min KT, Kim JW, Jeon YJ, Jang MJ, Chong SY, Oh D, Kim NK: Association of the miR-146aC>G, 149C>T, 196a2C>T, and 499A>G polymorphisms with colorectal cancer in the Korean population. Mol Carcinog 2012;51(suppl 1):E65-E73.
15. Wigginton JE, Cutler DJ, Abecasis GR: A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 2005;76:887-893.
16. Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-Analyses. BMJ 2003;327:557-560.
17. Begg CB, Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-1101.
18. Slaby O, Bienertova-Vasku J, Svoboda M, Vyzula R: Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer. J Cell Mol Med 2012;16:8-21.
19. Landau DA, Slack FJ: MicroRNAs in mutagenesis, genomic instability, and DNA repair. Semin Oncol 2011;38:743-751.
20. Xing J, Wan S, Zhou F, Qu F, Li B, Myers RE, Fu X, Palazzo JP, He X, Chen Z, Yang H: Genetic polymorphisms in pre-microRNA genes as prognostic markers of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2012;21:217-227.
21. Smits KM, Paranjape T, Nallur S, Wouters KA, Weijenberg MP, Schouten LJ, van den Brandt PA, Bosman FT, Weidhaas JB, van Engeland M: A let-7 microRNA SNP in the KRAS 3'UTR is prognostic in early-stage colorectal cancer. Clin Cancer Res 2011;17:7723-7731.
22. Guo J, Jin M, Zhang M, Chen K: A genetic variant in miR-196a2 increased digestive system cancer risks: a meta-Analysis of 15 case-control studies. PLoS One 2012;7:e30585.
23. Tian T, Xu Y, Dai J, Wu J, Shen H, Hu Z: Functional polymorphisms in two pre-microRNAs and cancer risk: a meta-Analysis. Int J Mol Epidemiol Genet 2010;1:358-366.
24. Gupta V, Richards S, Rowe J: Allogeneic, but not autologous, hematopoietic cell transplantation improves survival only among younger adults with acute lymphoblastic leukemia in first remission: an individual patient data meta-Analysis. Blood 2013;121:339-350.